Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland F Staack

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
Journal of Mass Spectrometry : JMS|July 4, 2006
New designer drug N-(1-phenylcyclohexyl)-3-ethoxypropanamine (PCEPA): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniquesChristoph Sauer, Frank T Peters, Roland F Staack, et al.
Forensic Science International|October 17, 2008
Metabolism and toxicological detection of the designer drug N-(1-phenylcyclohexyl)-3-methoxypropanamine (PCMPA) in rat urine using gas chromatography-mass spectrometryChristoph Sauer, Frank T Peters, Roland F Staack, et al.
Bioanalysis|March 11, 2011
Quality requirements for critical assay reagents used in bioanalysis of therapeutic proteins: what bioanalysts should know about their reagentsRoland F Staack, Jan O Stracke, Kay Stubenrauch, et al.
Journal of Mass Spectrometry : JMS|May 31, 2007
Analysis of erlotinib and its metabolites in rat tissue sections by MALDI quadrupole time-of-flight mass spectrometryLuca Signor, Emmanuel Varesio, Roland F Staack, et al.
The AAPS Journal|April 11, 2025
A Tool to Eliminate IgM Immunoassay InterferenceAlexander Pöhler, Uwe Wessels, Roland F Staack, et al.
Bioanalysis|December 5, 2024
A platform immunoassay for the quantification of biotherapeutics with glycine-serine linkersAlexander Pöhler, Michael Antony, Janine Faigle, et al.
Bioanalysis|July 29, 2022
Validation of a method to analyze size distribution of crovalimab-complement C5-eculizumab complexes in human serumMasanobu Nishidate, Norihito Shibahara, Akira Hayasaka, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 25, 2004
Identification of human cytochrome P450 2D6 as major enzyme involved in the O-demethylation of the designer drug p-methoxymethamphetamineRoland F Staack, Denis S Theobald, Liane D Paul, et al.
Bioanalysis|June 16, 2023
High ionic strength dissociation assay reduces dimeric target interference in immunogenicity testingAlexander Pöhler, Cordula Jany, Joachim Butzer, et al.
Analytical Chemistry|December 10, 2016
In Vivo Biotransformation of the Fusion Protein Tetranectin-Apolipoprotein A1 Analyzed by Ligand-Binding Mass Spectrometry Combined with Quantitation by ELISAManfred Zell, Christophe Husser, Roland F Staack, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Journal of Mass Spectrometry : JMS|July 4, 2006
New designer drug N-(1-phenylcyclohexyl)-3-ethoxypropanamine (PCEPA): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniquesChristoph Sauer, Frank T Peters, Roland F Staack, et al.
Forensic Science International|October 17, 2008
Metabolism and toxicological detection of the designer drug N-(1-phenylcyclohexyl)-3-methoxypropanamine (PCMPA) in rat urine using gas chromatography-mass spectrometryChristoph Sauer, Frank T Peters, Roland F Staack, et al.
Bioanalysis|March 11, 2011
Quality requirements for critical assay reagents used in bioanalysis of therapeutic proteins: what bioanalysts should know about their reagentsRoland F Staack, Jan O Stracke, Kay Stubenrauch, et al.
Journal of Mass Spectrometry : JMS|May 31, 2007
Analysis of erlotinib and its metabolites in rat tissue sections by MALDI quadrupole time-of-flight mass spectrometryLuca Signor, Emmanuel Varesio, Roland F Staack, et al.
The AAPS Journal|April 11, 2025
A Tool to Eliminate IgM Immunoassay InterferenceAlexander Pöhler, Uwe Wessels, Roland F Staack, et al.
Bioanalysis|December 5, 2024
A platform immunoassay for the quantification of biotherapeutics with glycine-serine linkersAlexander Pöhler, Michael Antony, Janine Faigle, et al.
Bioanalysis|July 29, 2022
Validation of a method to analyze size distribution of crovalimab-complement C5-eculizumab complexes in human serumMasanobu Nishidate, Norihito Shibahara, Akira Hayasaka, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 25, 2004
Identification of human cytochrome P450 2D6 as major enzyme involved in the O-demethylation of the designer drug p-methoxymethamphetamineRoland F Staack, Denis S Theobald, Liane D Paul, et al.
Bioanalysis|June 16, 2023
High ionic strength dissociation assay reduces dimeric target interference in immunogenicity testingAlexander Pöhler, Cordula Jany, Joachim Butzer, et al.
Analytical Chemistry|December 10, 2016
In Vivo Biotransformation of the Fusion Protein Tetranectin-Apolipoprotein A1 Analyzed by Ligand-Binding Mass Spectrometry Combined with Quantitation by ELISAManfred Zell, Christophe Husser, Roland F Staack, et al.
Pageof 9